Permanently Discontinued

CODEINE PHOSPHATE INJECTION USP

SANDOZ CANADA INCORPORATED

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is CODEINE PHOSPHATE INJECTION USP discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that CODEINE PHOSPHATE INJECTION USP 30MG has been permanently discontinued (last updated April 21, 2022). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is CODEINE PHOSPHATE INJECTION USP not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusPermanently Discontinued

Same-ingredient products on file4 products · 0 same form & route

Affected strength30MG

Report last updated2022-04-21

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

CODEINE 30

LABORATOIRE RIVA INC.

30MG · DIN 02009757

Same strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

TEVA-CODEINE

TEVA CANADA LIMITED

15MG · DIN 00593435

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

CODEINE PHOSPHATE SYRUP

LABORATOIRE ATLAS INC

25MG · DIN 00050024

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

LINCTUS CODEINE BLANC

LABORATOIRE ATLAS INC

10MG · DIN 00380571

Different strengthDifferent dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

DIN

00544884

Strength

30MG

Dosage Form

LIQUID

Route

SUBCUTANEOUS INTRAMUSCULAR

Active Ingredient

CODEINE PHOSPHATE

Tier

Unrated

Last Updated

2022-04-21

Reason for Shortage

Business reasons

Source

View original report on healthproductshortages.ca ↗

Other Products from SANDOZ CANADA INCORPORATED

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

ACETYLCYSTEINE SOLUTION

200MG · DIN 02243098

ACLASTA

5MG · DIN 02269198

ALFENTANIL INJECTION USP

500MCG · DIN 02248181

AMIKACIN SULFATE INJECTION USP

250MG · DIN 02242971

AMIODARONE HYDROCHLORIDE FOR INJECTION

50MG · DIN 02242325

AMOXICILLIN SODIUM AND POTASSIUM CLAVULANATE FOR INJECTION

DIN 02495929